RxDoctor Payments Data

Osahon Obakpolor, MD

Geriatric Medicine · Pittsburgh, PANPI 1477849628

Payments from drug & device makers

$355in general payments, 2019–2025

Across 22 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$73
  • Lilly USA, LLC$51
  • Acadia Pharmaceuticals Inc$46
  • Sunovion Pharmaceuticals Inc.$27
  • GSK$27
  • Merck$26
  • plus $106 from 7 others

What the payments were for

  • Food & beverage$355100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$355 in reported general payments places this provider in the 70th percentile of 217 geriatric medicine providers in Pennsylvania.

See all geriatric medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$302,493
Medicare patients
321
Services billed
2,583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban320$124,305
TrulicityDulaglutide52$50,200
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$32,670
XifaxanRifaximin19$28,200
MyrbetriqMirabegron102$28,040
JanuviaSitagliptin Phosphate64$21,579
JardianceEmpagliflozin61$19,953
MultaqDronedarone Hcl52$19,649
OzempicSemaglutide18$18,288
XareltoRivaroxaban34$15,480
Potassium Chloride296$14,479
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$9,417
VraylarCariprazine Hcl11$8,767
FarxigaDapagliflozin Propanediol16$7,872
Atorvastatin Calcium673$7,092

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$18$124,305320 claims
Lilly USA, LLCTrulicity$51$50,20052 claims
GSKTrelegy Ellipta$27$32,67049 claims
MerckJanuvia$26$21,57964 claims
Novo NordiskOzempic$73$18,28818 claims
AstraZenecaBreztri Aerosphere, Farxiga$13$17,28930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 217 geriatric medicine providers in Pennsylvania.

Other geriatric medicine in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →